SCHEDULE: T. Rowe Price Discloses 4.1% Stake in Molina Healthcare

Sentiment:

Beneficial Ownership Report


T. Rowe Price Associates, Inc. has disclosed a 4.1% beneficial ownership stake in Molina Healthcare Inc. common stock as of June 30, 2025.

Summary

  • T. Rowe Price Associates, Inc., an investment adviser based in Maryland, has filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Molina Healthcare Inc.
  • As of June 30, 2025, T. Rowe Price beneficially owns an aggregate of 2,207,124 shares of Molina Healthcare Inc. common stock.
  • This ownership represents 4.1% of the class of securities.
  • T. Rowe Price holds sole voting power over 2,124,376 shares and sole dispositive power over 2,206,422 shares.
  • The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Molina Healthcare Inc.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual disclosure of beneficial ownership by an institutional investor, providing no direct positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an institutional investor's stake in a healthcare company. It reflects T. Rowe Price's ongoing investment activities within the healthcare sector, a segment often favored by long-term institutional investors due to its defensive characteristics and growth potential.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence investor perception and confidence.

Key Dates

DateDescription
06/30/2025Date of event which requires filing of this statement, indicating the beneficial ownership position.
08/14/2025Date the Schedule 13G Amendment No. 1 was signed by T. Rowe Price Associates, Inc.

Keywords

Molina Healthcare, T. Rowe Price, Healthcare, Investment Adviser, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Schedule 13G

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.